Senseonics Holdings Inc SENS
News
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
Senseonics To Participate in Upcoming Institutional Investor Conferences
Senseonic Shares Slide on Underwritten Offering Price

